IRIS
GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.164
NA - Nord America 2.668
EU - Europa 1.485
SA - Sud America 752
AF - Africa 72
OC - Oceania 68
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.213
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 8.187
US - Stati Uniti d'America 2.561
CN - Cina 1.312
HK - Hong Kong 962
BR - Brasile 568
IT - Italia 423
VN - Vietnam 382
GB - Regno Unito 331
DE - Germania 199
NL - Olanda 132
IN - India 88
AR - Argentina 74
EE - Estonia 73
AU - Australia 68
CA - Canada 65
ID - Indonesia 65
CZ - Repubblica Ceca 52
FI - Finlandia 40
EC - Ecuador 38
ZA - Sudafrica 37
FR - Francia 35
UA - Ucraina 33
MX - Messico 31
JP - Giappone 27
BD - Bangladesh 25
RU - Federazione Russa 25
ES - Italia 22
PL - Polonia 22
TR - Turchia 21
IR - Iran 19
CL - Cile 17
CO - Colombia 15
PY - Paraguay 15
BE - Belgio 14
SE - Svezia 14
MA - Marocco 11
LT - Lituania 9
BO - Bolivia 8
PE - Perù 8
PH - Filippine 8
PK - Pakistan 8
AT - Austria 7
CH - Svizzera 7
MY - Malesia 7
RO - Romania 7
TH - Thailandia 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 5
GR - Grecia 5
IQ - Iraq 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
IE - Irlanda 4
IL - Israele 4
NP - Nepal 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
EG - Egitto 3
KZ - Kazakistan 3
MK - Macedonia 3
NO - Norvegia 3
PT - Portogallo 3
AM - Armenia 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
LU - Lussemburgo 2
OM - Oman 2
RS - Serbia 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
NA - Namibia 1
NI - Nicaragua 1
PA - Panama 1
RE - Reunion 1
Totale 16.208
Salva come PNG Salva come JPEG
Città #
Hong Kong 951
Ashburn 887
Singapore 868
Hefei 613
Dallas 398
Boardman 368
London 271
Shanghai 204
Beijing 189
Ho Chi Minh City 137
Rome 114
Amsterdam 102
Council Bluffs 96
Hanoi 88
Munich 74
Tallinn 68
Los Angeles 67
São Paulo 51
San Francisco 46
Washington 43
Milan 41
Seattle 41
Brno 39
Santa Clara 36
Pune 30
West Jordan 26
Tokyo 24
Montreal 22
Perth 22
Brooklyn 21
Helsinki 21
Rio de Janeiro 21
Melbourne 20
New York 20
Toronto 19
Frankfurt am Main 18
Turku 18
Warsaw 18
Mexico City 17
Boston 15
Chennai 15
Chicago 15
Johannesburg 14
Brasília 13
Da Nang 13
Jinan 13
Thái Bình 13
Haiphong 12
Quito 12
Bengaluru 11
Hanover 11
Jakarta 11
Santiago 11
Biên Hòa 10
Guayaquil 10
Olomouc 10
Reggio Emilia 10
Salvador 10
Stockholm 10
Sydney 10
Buenos Aires 9
Bắc Ninh 9
Hải Dương 9
Porto Alegre 9
Xi'an 9
Zhengzhou 9
Bari 8
Belo Horizonte 8
Canberra 8
Oxford 8
Brussels 7
Campinas 7
Dhaka 7
Hamburg 7
Hortolândia 7
Manchester 7
Paris 7
Qingdao 7
San Jose 7
Turin 7
Asunción 6
Bocholt 6
Bologna 6
Buffalo 6
Can Tho 6
Caxias do Sul 6
Delhi 6
Fortaleza 6
Madrid 6
Manaus 6
Mauá 6
Phoenix 6
Secaucus 6
Viamão 6
Zhoukou 6
Ankara 5
Atlanta 5
Bangkok 5
Bogotá 5
Denver 5
Totale 6.629
Salva come PNG Salva come JPEG
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 414
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 233
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 216
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 213
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 210
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 207
Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? 206
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 205
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 204
Simultaneous presence of Brugada and overgrowth syndromes 203
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 201
An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. 200
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 198
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 198
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 197
A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise 196
Current management and prognosis of patients with recurrent myocardial infarction 193
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 193
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 192
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 191
Assessment of cardiopulmonary capacity in deconditioned athletes because of knee injury 191
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 189
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. 189
Age and heart transplantation: results from a heart failure management unit. 189
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 187
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 186
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 182
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma 181
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 180
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 175
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 163
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 146
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 142
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 123
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 119
A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure 110
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 109
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 107
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 105
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 103
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 103
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 101
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus 100
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 97
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 97
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 96
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 95
Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR 95
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 92
Breath Analysis via Gas Chromatography-Mass Spectrometry (GC-MS) in Chronic Coronary Syndrome (CCS): A Proof-of-Concept Study 92
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 92
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 90
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 88
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 85
Invasive Assessment of Coronary Microvascular Function 81
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 80
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 79
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum 79
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? 76
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study 75
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 71
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 70
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 66
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 63
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis 62
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 62
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 53
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 50
Evaluation of postural disorders in patients pre and post heart transplant. 47
Eosinophilic Myocarditis: From Bench to Bedside 46
The current paradigm of cardiac troponin increase among athletes 46
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 45
Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry 43
Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality = Sistemi di ossigenazione a membrana extracorporea come trattamento per lo shock cardiogeno refrattario nella popolazione adulta: strategie, risultati e predittori di mortalità 43
Effects of Environmental Conditions on Athlete's Cardiovascular System 42
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure 42
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 41
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 41
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 41
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 41
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 40
Malattie valvolari, febbre reumatica 40
Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? 40
Reappraisal of the Concept and Implications of Pulmonary Hypertension in Degenerative Mitral Regurgitation 40
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 39
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 39
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 39
Mechanical circulatory support with centrifugal pump as bridge to heart transplantation 38
Ruolo residuo della terapia medica e con device nei pazienti affetti da scompenso cardiaco cronico riferiti per trapianto 38
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 38
Unusual rapid evolution of type B aortic dissection in a Marfan patient following heart transplantation: successful endovascular treatment. 38
Studio prospettico randomizzato sull'effetto della terapia con acido folico nella preenzione della malattia coronarica nel paziente trapiantato 38
Significato prognostico dei livelli plasmatici di endotelina-1 in pazienti con ipertensione arteriosa polmonare primitiva 38
Factors influencing post-surgical survival in degenerative mitral regurgitation 38
Management of asymptomatic mitral regurgitation. 37
QRS interval time-related changes and prognosis in heart failure. 37
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 37
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 37
 RELAZIONE TRA PROFILO NEUROORMONALE E SOPRAVVIVENZA IN PAZIENTI CON IPERTENSIONE POLMONARE PRIMITIVA O PRECAPILLARE SECONDARIA 37
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 37
Totale 10.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022331 0 2 7 11 6 9 6 3 15 16 13 243
2022/2023283 10 9 22 18 29 4 10 11 6 7 153 4
2023/20241.461 24 115 82 90 109 459 58 304 64 72 24 60
2024/202510.194 211 100 368 177 83 286 192 61 760 713 3.500 3.743
2025/20264.120 822 376 849 1.295 435 343 0 0 0 0 0 0
Totale 16.389